Aurobindo Pharma Expands Domestic Reach With ₹325 Crore Deal.
Pune, India | January 02, 2026 Aurobindo Pharma has successfully acquired Khandelwal Laboratories’ non-oncology prescription business through a ₹325 crore deal. This acquisition enhances the
Read More